Hosted on MSN1y
Some lymphomas become resistant to treatment. Gene discovery may offer path to overcome it.
BTK inhibitors, including the commonly used drug ibrutinib, block B cells' signaling pathway. This is helpful for treating B-cell lymphomas because the cancers arise when this signaling pathway ...
The American Journal of Managed Care3d
Future Directions and Overcoming Challenges in BTK Inhibitor Therapy
Patient-Centered Selection of BTK Inhibitors: Balancing Clinical Factors and Patient Preferences EP: 16 . Implementation of Shared Decision-Making in BTK Inhibitor Treatment ...